Some researchers use tissue biomarkers (TFF2, mir-124a-3p, etc.), innovative blood biomarkers, and other low-cost markers (CEA, CA19-9, MUC16, etc.)to predict and evaluate the risk of gastric cancer. The gene discussed is TFF2; the disease is gastric cancer.